These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


215 related items for PubMed ID: 28836790

  • 1. Stabilizing Unstable Amorphous Menthol through Inclusion in Mesoporous Silica Hosts.
    Cordeiro T, Castiñeira C, Mendes D, Danède F, Sotomayor J, Fonseca IM, Gomes da Silva M, Paiva A, Barreiros S, Cardoso MM, Viciosa MT, Correia NT, Dionisio M.
    Mol Pharm; 2017 Sep 05; 14(9):3164-3177. PubMed ID: 28836790
    [Abstract] [Full Text] [Related]

  • 2. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC, Viciosa MT, Danède F, Affouard F, Correia NT.
    Mol Pharm; 2014 Jan 06; 11(1):112-30. PubMed ID: 24215236
    [Abstract] [Full Text] [Related]

  • 3. How Molecular Mobility, Physical State, and Drug Distribution Influence the Naproxen Release Profile from Different Mesoporous Silica Matrices.
    d'Orey P, Cordeiro T, Lourenço MAO, Matos I, Danède F, Sotomayor JC, Fonseca IM, Ferreira P, Correia NT, Dionísio M.
    Mol Pharm; 2021 Mar 01; 18(3):898-914. PubMed ID: 33461296
    [No Abstract] [Full Text] [Related]

  • 4. Characterising glass transition temperatures and glass dynamics in mesoporous silica-based amorphous drugs.
    Kissi EO, Ruggiero MT, Hempel NJ, Song Z, Grohganz H, Rades T, Löbmann K.
    Phys Chem Chem Phys; 2019 Sep 11; 21(35):19686-19694. PubMed ID: 31469369
    [Abstract] [Full Text] [Related]

  • 5. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J, Menegotto J, Cardon P, Duplaa H, Caron A, Lacabanne C, Bauer M.
    J Pharm Sci; 2004 Jan 11; 93(1):218-33. PubMed ID: 14648651
    [Abstract] [Full Text] [Related]

  • 6. A novel strategy to design sustained-release poorly water-soluble drug mesoporous silica microparticles based on supercritical fluid technique.
    Li-Hong W, Xin C, Hui X, Li-Li Z, Jing H, Mei-Juan Z, Jie L, Yi L, Jin-Wen L, Wei Z, Gang C.
    Int J Pharm; 2013 Sep 15; 454(1):135-42. PubMed ID: 23871738
    [Abstract] [Full Text] [Related]

  • 7. 2H-solid state NMR and DSC study of isobutyric acid in mesoporous silica materials.
    Vyalikh A, Emmler T, Shenderovich I, Zeng Y, Findenegg GH, Buntkowsky G.
    Phys Chem Chem Phys; 2007 Jun 14; 9(18):2249-57. PubMed ID: 17487322
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Stability of amorphous drug, 2-benzyl-5-(4-chlorophenyl)-6-[4-(methylthio)phenyl]-2H-pyridazin-3-one, in silica mesopores and measurement of its molecular mobility by solid-state (13)C NMR spectroscopy.
    Miura H, Kanebako M, Shirai H, Nakao H, Inagi T, Terada K.
    Int J Pharm; 2011 May 30; 410(1-2):61-7. PubMed ID: 21421036
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Interfacial effects on vitrification of confined glass-forming liquids.
    Trofymluk O, Levchenko AA, Navrotsky A.
    J Chem Phys; 2005 Nov 15; 123(19):194509. PubMed ID: 16321102
    [Abstract] [Full Text] [Related]

  • 13. Solid State NMR Characterization of Ibuprofen:Nicotinamide Cocrystals and New Idea for Controlling Release of Drugs Embedded into Mesoporous Silica Particles.
    Skorupska E, Kaźmierski S, Potrzebowski MJ.
    Mol Pharm; 2017 May 01; 14(5):1800-1810. PubMed ID: 28403609
    [Abstract] [Full Text] [Related]

  • 14. Dissolution enhancement of active pharmaceutical ingredients by therapeutic deep eutectic systems.
    Aroso IM, Silva JC, Mano F, Ferreira AS, Dionísio M, Sá-Nogueira I, Barreiros S, Reis RL, Paiva A, Duarte AR.
    Eur J Pharm Biopharm; 2016 Jan 01; 98():57-66. PubMed ID: 26586342
    [Abstract] [Full Text] [Related]

  • 15. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
    Yoshioka M, Hancock BC, Zografi G.
    J Pharm Sci; 1994 Dec 01; 83(12):1700-5. PubMed ID: 7891297
    [Abstract] [Full Text] [Related]

  • 16. Molecular dynamics of ethylene glycol dimethacrylate glass former: influence of different crystallization pathways.
    Viciosa MT, Correia NT, Salmerón Sánchez M, Gómez Ribelles JL, Dionísio M.
    J Phys Chem B; 2009 Oct 29; 113(43):14196-208. PubMed ID: 19845405
    [Abstract] [Full Text] [Related]

  • 17. Melting and freezing of water in cylindrical silica nanopores.
    Jähnert S, Vaca Chávez F, Schaumann GE, Schreiber A, Schönhoff M, Findenegg GH.
    Phys Chem Chem Phys; 2008 Oct 21; 10(39):6039-51. PubMed ID: 18825292
    [Abstract] [Full Text] [Related]

  • 18. Investigating the influence of morphology in the dynamical behavior of semicrystalline Triton X-100: insights in the detection/nondetection of the α'-process.
    Merino EG, Danéde F, Derrollez P, Dias CJ, Viciosa MT, Correia NT, Dionísio M.
    J Phys Chem B; 2013 Aug 22; 117(33):9793-805. PubMed ID: 23937121
    [Abstract] [Full Text] [Related]

  • 19. Tuning the Physical State of Aripiprazole by Mesoporous Silica.
    Kramarczyk D, Knapik-Kowalczuk J, Klimontko J, Kurek M, Jachowicz R, Paluch M.
    Mol Pharm; 2024 May 06; 21(5):2315-2326. PubMed ID: 38644570
    [Abstract] [Full Text] [Related]

  • 20. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
    Shete G, Khomane KS, Bansal AK.
    J Pharm Sci; 2014 Jan 06; 103(1):167-78. PubMed ID: 24186540
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 11.